Q-Line Biotech

  • Market Cap: N/A
  • Industry: Healthcare Services
  • ISIN: INE1G2W01011
  • NSEID: QLINE
  • BSEID:
INR
474.60
131.6 (38.37%)
BSENSE

May 29

BSE+NSE Vol: 3673600

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'25
Mar'24
Mar'23
EQUITY AND LIABILITIES
No of Months
12
12
12
Share Capital
1.57
1.57
1.57
Share Warrants & Outstandings
Total Reserve
188.37
160.24
125.79
Shareholder's Funds
189.95
161.81
127.37
Minority Interest
0.00
0.00
0.00
Long-Term Borrowings
82.41
35.09
14.31
Secured Loans
82.19
32.29
10.39
Unsecured Loans
0.22
2.80
3.91
Deferred Tax Assets / Liabilities
-0.98
-0.58
-0.71
Other Long Term Liabilities
3.99
2.06
1.76
Long Term Trade Payables
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
Total Non-Current Liabilities
85.42
36.58
15.36
Current Liabilities
Trade Payables
55.62
59.24
39.71
Other Current Liabilities
40.98
19.22
9.10
Short Term Borrowings
82.54
61.82
59.34
Short Term Provisions
0.00
0.00
0.00
Total Current Liabilities
179.14
140.28
108.15
Total Liabilities
454.50
338.67
250.87
ASSETS
Non-Current Assets
0.00
0.00
0.00
Gross Block
93.49
72.66
31.61
Less: Accumulated Depreciation
19.86
12.73
8.81
Less : Impairment of Assets
0.00
0.00
0.00
Net Block
73.63
59.92
22.80
Lease Adjustment
0.00
0.00
0.00
Capital Work in Progress
59.03
19.17
11.74
Intangible assets under development
3.52
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
Non Current Investments
17.95
28.51
15.70
Long Term Loans & Advances
1.58
8.89
10.00
Other Non Current Assets
34.41
23.64
14.51
Total Non-Current Assets
189.87
140.14
74.76
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
Inventories
90.21
105.24
43.59
Sundry Debtors
82.60
26.44
33.06
Cash and Bank
47.03
29.96
90.02
Other Current Assets
12.22
0.16
0.10
Short Term Loans and Advances
32.58
36.73
9.34
Total Current Assets
264.64
198.53
176.11
Net Current Assets (Including Current Investments)
85.50
58.25
67.96
Total Current Assets Excluding Current Investments
264.64
198.53
176.11
Miscellaneous Expenses not written off
0.00
0.00
0.00
Total Assets
454.50
338.67
250.87
Contingent Liabilities
19.30
14.93
14.72
Total Debt
164.95
96.91
73.65
Book Value per share (adjusted)
0
0
0
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2025 is 70.21% vs 31.58% in Mar 2024

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2025 is 93.69% vs 17.05% in Mar 2024

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2025 is 67.75% vs 128.98% in Mar 2024

stock-summary

Investments

YoY Growth in year ended Mar 2025 is -37.04% vs 81.59% in Mar 2024

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is 33.30% vs 12.73% in Mar 2024

Compare Balance Sheet Results of Q-Line Biotech
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
1.57
0
1.57
0.00%
Share Warrants & Outstandings
Total Reserve
188.37
0
188.37
0.00%
Shareholder's Funds
189.95
0
189.95
0.00%
Minority Interest
0.00
0
0.00
0.00%
Long-Term Borrowings
82.41
0
82.41
0.00%
Secured Loans
82.19
0
82.19
0.00%
Unsecured Loans
0.22
0
0.22
0.00%
Deferred Tax Assets / Liabilities
-0.98
0
-0.98
0.00%
Other Long Term Liabilities
3.99
0
3.99
0.00%
Long Term Trade Payables
0.00
0
0.00
0.00%
Long Term Provisions
0.00
0
0.00
0.00%
Total Non-Current Liabilities
85.42
0
85.42
0.00%
Current Liabilities
Trade Payables
55.62
0
55.62
0.00%
Other Current Liabilities
40.98
0
40.98
0.00%
Short Term Borrowings
82.54
0
82.54
0.00%
Short Term Provisions
0.00
0
0.00
0.00%
Total Current Liabilities
179.14
0
179.14
0.00%
Total Liabilities
454.50
0
454.50
0.00%
ASSETS
Non-Current Assets
0.00
0
0.00
0.00%
Gross Block
93.49
0
93.49
0.00%
Less: Accumulated Depreciation
19.86
0
19.86
0.00%
Less : Impairment of Assets
0.00
0
0.00
0.00%
Net Block
73.63
0
73.63
0.00%
Lease Adjustment
0.00
0
0.00
0.00%
Capital Work in Progress
59.03
0
59.03
0.00%
Intangible assets under development
3.52
0
3.52
0.00%
Pre-operative Expenses pending
0.00
0
0.00
0.00%
Assets in transit
0.00
0
0.00
0.00%
Non Current Investments
17.95
0
17.95
0.00%
Long Term Loans & Advances
1.58
0
1.58
0.00%
Other Non Current Assets
34.41
0
34.41
0.00%
Total Non-Current Assets
189.87
0
189.87
0.00%
Current Assets Loans & Advances
Current Investments
0.00
0
0.00
0.00%
Inventories
90.21
0
90.21
0.00%
Sundry Debtors
82.60
0
82.60
0.00%
Cash and Bank
47.03
0
47.03
0.00%
Other Current Assets
12.22
0
12.22
0.00%
Short Term Loans and Advances
32.58
0
32.58
0.00%
Total Current Assets
264.64
0
264.64
0.00%
Net Current Assets (Including Current Investments)
85.50
0
85.50
0.00%
Total Current Assets Excluding Current Investments
264.64
0
264.64
0.00%
Miscellaneous Expenses not written off
0.00
0
0.00
0.00%
Total Assets
454.50
0
454.50
0.00%
Contingent Liabilities
19.30
0
19.30
0.00%
Total Debt
164.95
0
164.95
0.00%
Book Value per share (adjusted)
0.00
0
0.00
0.00%
Annual - Borrowings
Borrowings 164.95 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 70.21% vs 31.58% in Mar 2024

Annual - Other Long Term Liabilities
Other Long Term Liabilities 3.99 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 93.69% vs 17.05% in Mar 2024

Annual - Fixed Assets
Fixed Assets 132.67 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 67.75% vs 128.98% in Mar 2024

Annual - Investments
Investments 17.95 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -37.04% vs 81.59% in Mar 2024

Annual - Current Assets
Current Assets 264.64 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 33.30% vs 12.73% in Mar 2024